SENTAN Pharma SENTAN Pharma

日本語 ENGLISH

History

February 2007 Established Advanced Medical Frontier Co., Ltd. venture at Kyushu University and concluded a joint research contract with Kyushu University.
July 2009 2009 Fukuoka Prefecture Bio-Venture Development Project Adopted
January 2010 Established Okinawa Research Institute, Uruma City, Okinawa Prefecture
February 2010 Received the JAPAN 10th Bio-Business Competition Judging Committee Special Award
April 2011 2011 Okinawa-type Industry Support Fund Business
June 2011 We adopted a research-based construction project for intellectual cluster formation.
September 2014 2014 Okinawa Prefecture Life Science Network Formation Project Adopted
October 2015 National Research and Development Corporation New Energy and Industrial Technology Development Organization (NEDO) Adopted 2015 Innovative Manufacturing Industry Creation Cooperation Promotion Project
June 2016 2016 Okinawa Science and Technology Innovation System Construction Project Adopted
June 2017 2017 Okinawa Science and Technology Innovation Joint Research Promotion Subsidy Adopted 2017 Growth Field Leading Project Creation Project Adopted
October 2018 A license agreement with Shanghai Kaiti Biopharmaceutical Technology Co., Ltd. for manufacturing and marketing rights in China for statin-encapsulated nanoparticle preparations.
September 2020 Company name changed from Advanced Medical Frontier Co., Ltd. to SENTAN Pharma Co., Ltd.
September 2020 The Japan Agency for Medical Research and Development (AMED) adopted an innovative drug development promotion project for emerging and re-emerging infectious diseases (development of therapeutic drugs for new coronavirus infection (COVID-19))
April 2021 Moved to the research institute in Kurume City, Fukuoka Prefecture
June 2021 Fukuoka Prefecture New Product / New Technology Creation Research and Development Support Project Adopted: